Overview
MRNA market data
Price History
MRNA price chart · 1M
- O
- 153.81
- H
- 153.81
- L
- 141.69
- C
- 145.52
- Vol
- 483,276.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $153.81
- Previous Close
- $148.81
- Day High
- $153.81
- Day Low
- $141.69
- 52 Week High
- $176.60
- 52 Week Low
- $44.04
- 7 Day Return
- +5.50%
- 30 Day Return
- +158.83%
- 90 Day Return
- +205.67%
- 1 Year Return
- +175.08%
- Daily Notional Volume
- $70.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$7.25 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.22 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -141.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $22.28 – $176.66 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $58.6B · P/B 1.33 · P/S 26.28.
Company News
10 captured
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?Zacks Investment Research ·
Moderna shares are trading lower after Rothschild & Co downgraded the stock from Neutral to Sell.Benzinga ·
Is BioNTech Stock a No-Brainer Buy on the Dip?The Motley Fool ·